Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Fuction | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16137634 | 2005 | RQIKIWFQNRRMKWKK{ct:Amid} | pAntp(43–58) | Amidation | Free | Linear | L | None | 16 | CPP | 20.0±1.8% hemolysis at 50µM | Bovine | Penetratin (fragment of Antennapedia homeodomain) | NA | NA | ||
| 16137634 | 2005 | GRKKRRQRRRPPQ{ct:Amid} | pTAT(48–60) | Amidation | Free | Linear | L | None | 13 | CPP | 11.2±1.5% hemolysis at 50µM | Bovine | Fragment of transcription factor coded by theTat protein (HIV virus) | NA | NA | ||
| 16137634 | 2005 | LLIILRRRIRKQAHAHSK{ct:Amid} | pVEC(615–632) | Amidation | Free | Linear | L | None | 18 | CPP | 18.1±0.3% hemolysis at 50µM | Bovine | Vascular endothelial cadherin protein (Murine) | NA | NA | ||
| 16137634 | 2005 | KLALKLALKALKAALKLA{ct:Amid} | MAP | Amidation | Free | Linear | L | None | 18 | CPP | 20.9±1.8% hemolysis at 50µM | Bovine | Synthetic peptide | NA | NA | ||
| 16137634 | 2005 | AGYLLGKINLKALAALAKKIL{ct:Amid} | Transportan 10 | Amidation | Free | Linear | L | None | 21 | CPP | 29.0±4.9% hemolysis at 50µM | Bovine | Galanin and Mastoparan fragments | NA | NA | ||
| 22328546 | 2012 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | CPP | >80% hemolytic at 25μM at pH 8 | Human | Melittin (Apis mellifera) | NA | NA | ||
| 22328546 | 2012 | GIGAVLKVLTTGLPALISWIKRKRQQ | Melittin | Free | Free | Linear | L | None | 26 | CPP | <60% hemolytic at 25μM at pH 6 | Human | Melittin (Apis mellifera) | NA | NA | ||
| 22328546 | 2012 | GIGAVLKVLTTGLPALISWI | MT20 | Free | Free | Linear | L | None | 20 | CPP | <80% hemolytic at 25μM at pH 8 | Human | Truncated peptides of melittin | NA | NA | ||
| 22328546 | 2012 | GIGAVLKVLTTGLPALISWI | MT20 | Free | Free | Linear | L | None | 20 | CPP | 40% hemolytic at 25μM at pH 5 | Human | Truncated peptides of melittin | NA | NA | ||
| 22328546 | 2012 | GIGAILKVLATGLPTLISWIKNKRKQ | Florae | Free | Free | Linear | L | None | 26 | CPP | <70% hemolytic at 25μM at pH 6 | Human | Melittin analog | NA | NA | ||
| 22328546 | 2012 | GIGAILKVLATGLPTLISWIKNKRKQ | Florae | Free | Free | Linear | L | None | 26 | CPP | ~80% hemolytic at 25μM at pH 8 | Human | Melittin analog | NA | NA | ||
| 22328546 | 2012 | GIGAILKVLATGLPTLISWI | FL20 | Free | Free | Linear | L | None | 20 | CPP | <60% hemolytic at 25μM at pH 5 | Human | Truncated peptides of florae (Apis florae) | NA | NA | ||
| 22328546 | 2012 | GIGAILKVLATGLPTLISWI | FL20 | Free | Free | Linear | L | None | 20 | CPP | ~80% hemolytic at 25μM at pH 8 | Human | Truncated peptides of florae (Apis florae) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRIRKQAHAHSK{ct:Amid} | pVEC | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRWRKQARARSK{ct:Amid} | pVEC-a1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRWRKQAKAKSK{ct:Amid} | pVEC-a2 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILRRRWRRQARARSR{ct:Amid} | pVEC-a3 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 94μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 21956793 | 2011 | LLIILKKKWKKQAKAKSK{ct:Amid} | pVEC-a4 | Amidation | Free | Linear | L | None | 18 | Antimicrobial and CPP | >10% hemolytic at 200μM | Human | Vascular endothelial-cadherin protein derivative analog (Murine) | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAGLLSNL{ct:Amid} | Alyteserin-2a | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =140μM | Human | Derived from skin secretions of Alytes obstetricans (alyteserin-2a) | α-helical | NA | ||
| 22965637 | 2013 | ILKKLLSTAAGLLSNL{ct:Amid} | G3K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =105μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLKTAAGLLSNL{ct:Amid} | S7K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =28μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLK{d}TAAGLLSNL{ct:Amid} | S7k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =105μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAKLLSNL{ct:Amid} | G11K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =24μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAK{d}LLSNL{ct:Amid} | G11k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =42μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAGLLKNL{ct:Amid} | S14K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =55μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAGLLSKL{ct:Amid} | N15K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =50μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAGLLSK{d}L{ct:Amid} | N15k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =310μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLKTAAKLLSNL{ct:Amid} | S7K,G11K | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =38μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLK{d}TAAK{d}LLSNL{ct:Amid} | S7k,G11k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =185μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAKLLSKL{ct:Amid} | G11K,N15K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =16μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAAK{d}LLSKL{ct:Amid} | G11k,N15K | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =195μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSWAAGLLSNL{ct:Amid} | T8W | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =13μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTWAGLLSNL{ct:Amid} | A9W | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =39μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAWGLLSNL{ct:Amid} | A10W | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =11μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAWK{d}LLSNL{ct:Amid} | A10W,G11k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =21μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAWGLLSKL{ct:Amid} | A10W,N15K | Amidation | Free | Linear | L | None | 16 | CPP | LC50 =6μM | Human | Alyteserin-2a analog | NA | NA | ||
| 22965637 | 2013 | ILGKLLSTAWALLSK{d}L{ct:Amid} | A10W,N15k | Amidation | Free | Linear | Mix | None | 16 | CPP | LC50 =27μM | Human | Alyteserin-2a analog | NA | NA | ||
| 23776609 | 2013 | RAGLQFPVGRLLR | BR1 | Free | Free | Linear | L | None | 13 | CPP | Inactive | Human | buforin IIb | NA | Non-hemolytic | ||
| 23776609 | 2013 | RAGLQFPVGRLLRRLLR | BR2 | Free | Free | Linear | L | None | 17 | CPP | Inactive | Human | buforin IIb | NA | Non-hemolytic | ||
| 23776609 | 2013 | RAGLQFPVGRLLRRLLRRLLR | BR3 | Free | Free | Linear | L | None | 21 | CPP | 5% hemolysis at 25μM | Human | buforin IIb | NA | NA | ||
| 23776609 | 2013 | RAGLQFPVGRLLRRLLRRLLR | BR3 | Free | Free | Linear | L | None | 21 | CPP | 34.3% hemolysis at 200μM | Human | buforin IIb | NA | NA | ||
| 23776609 | 2013 | RKKRRQRRR | Tat (49–57) | Free | Free | Linear | L | None | 9 | CPP | Inactive | Human | buforin IIb | NA | Non-hemolytic | ||
| 29411917 | 2018 | aza-β3Lys-K-{nnr:aza-β3-1Nal}-K-{nnr:aza-β3-1Nal}-L{cyc:N-C} | ACPP20 | Free | Free | Cyclic | L | aza-β3-Lys = aza-β3-Lysine, aza-β3-1Nal = aza-β3-1-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 1.5 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | Low hemolytic | ||
| 29411917 | 2018 | aza-β3Lys-K-{nnr:aza-β3-2Nal}-L-{nnr:aza-β3-2Nal}-L{cyc:N-C} | ACPP21 | Free | Free | Cyclic | L | aza-β3-Lys = aza-β3-Lysine, aza-β3-2Nal = aza-β3-2-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 8 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | NA | ||
| 29411917 | 2018 | aza-β3Lys-K-{nnr:aza-β3-1Nal}-L-{nnr:aza-β3-4Fluo-1Nal}-L{cyc:N-C} | ACPP22 | Free | Free | Cyclic | L | aza-β3-Leu = aza-β3-Leucine, aza-β3-1Nal = aza-β3-1-Naphthylalanine, aza-β3-4Fluo-1Nal = aza-β3-4Fluoro-1-Nahphtylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 5 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | Low hemolytic | ||
| 29411917 | 2018 | K-aza-β3Lys-L-{nnr:aza-β3-1Nal}-aza-β3Leu-{nnr:aza-β3-1Nal}{cyc:N-C} | ACPP23 | Free | Free | Cyclic | L | aza-β3-Lys = aza-β3-Lysine, aza-β3-1Nal = aza-β3-1-Naphthylalanine, aza-β3-Leu = aza-β3-Leucine, aza-β3-1Nal = aza-β3-1-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 6 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | NA | ||
| 29411917 | 2018 | aza-β3Arg-R-{nnr:aza-β3-1Nal}-L-{nnr:aza-β3-1Nal}-L{cyc:N-C} | ACPP24 | Free | Free | Cyclic | L | aza-β3-Arg = aza-β3-Arginine, aza-β3-1Nal = aza-β3-1-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 12 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | NA | ||
| 29411917 | 2018 | aza-β3Lys-R-{nnr:aza-β3-2Nal}-F-{nnr:aza-β3-2Nal}-F{cyc:N-C} | ACPP25 | Free | Free | Cyclic | L | aza-β3-Lys = aza-β3-Lysine, aza-β3-2Nal = aza-β3-2-Naphthylalanine | 6 | Antimicrobial cyclic pseudopeptides (ACPPs) | 50 % Hemolysis at 100 µM | Sheep | Synthesis Of Mixed Aza-Β3-Pseudopeptides | NA | NA | ||
| 32024261 | 2020 | KARKKKLNKKGRKMAGRKRGRPKK | Dot1l | Free | Free | Linear | L | None | 24 | CPPs (Cell-penetrating peptides) | <0.5 % Hemolysis at 10 μM | Human | Human Gene Dot1L | α-Helical | Non-hemolytic | ||
| 32024261 | 2020 | KARKKKLNKKGRKMAGRKRGRPKK | Dot1l | Free | Free | Linear | L | None | 24 | CPPs (Cell-penetrating peptides) | <0.5 % Hemolysis at 7.5 μM | Human | Human Gene Dot1L | α-Helical | Non-hemolytic |